Last reviewed · How we verify
Teprotumumab Injection [Tepezza] — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Teprotumumab Injection [Tepezza] (Teprotumumab Injection [Tepezza]) — Walter Reed National Military Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Teprotumumab Injection [Tepezza] TARGET | Teprotumumab Injection [Tepezza] | Walter Reed National Military Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Teprotumumab Injection [Tepezza] CI watch — RSS
- Teprotumumab Injection [Tepezza] CI watch — Atom
- Teprotumumab Injection [Tepezza] CI watch — JSON
- Teprotumumab Injection [Tepezza] alone — RSS
Cite this brief
Drug Landscape (2026). Teprotumumab Injection [Tepezza] — Competitive Intelligence Brief. https://druglandscape.com/ci/teprotumumab-injection-tepezza. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab